EGFR and skin squamous cell carcinoma: Besides the PI3K/AKT/mTOR pathway inhibitors, the Hedgehog pathway, and the epidermal growth factor receptor pathway, there are new molecular targets that are being looked at to treat cSCC (Chamcheu et al., 2019[36]).